What happened, in summary

A 64-year-old woman was being prepared for lumpectomy after a diagnosis of invasive ductal carcinoma of the breast. Preoperative blood testing unexpectedly showed marked elevation of her white blood cell and platelet counts. A chest X-ray obtained during the surgical workup then revealed a large right upper-lobe mass and a second nodule in the left lung. Further investigation established a separate, advanced lung adenocarcinoma. Because the lung cancer carried a poor prognosis and became the immediate clinical priority, the planned breast operation did not proceed. She started daily anastrozole for the breast cancer while receiving palliative treatment for the lung primary. Her breast treatment remained limited to endocrine therapy while the newly discovered lung cancer became the immediate clinical priority. During the following months, her overall condition was dominated by complications of the lung malignancy, including extreme leukocytosis, limb-threatening arterial insufficiency, and eventual acute hypoxic respiratory failure. She chose comfort-focused measures and died shortly afterward. Her breast-cancer pathway therefore consisted of endocrine therapy rather than the initially planned lumpectomy, with the treatment plan altered by discovery of a simultaneous stage IV lung cancer.